 Ryan Baxter
Concepts (144)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Polyethylenes | 6 | 2013 | 14 | 1.570 |
Why?
| | Hip Prosthesis | 4 | 2011 | 37 | 1.100 |
Why?
| | Lupus Nephritis | 1 | 2023 | 49 | 0.840 |
Why?
| | Prosthesis Failure | 4 | 2013 | 113 | 0.840 |
Why?
| | Lupus Erythematosus, Systemic | 1 | 2023 | 245 | 0.700 |
Why?
| | Hip Joint | 2 | 2011 | 157 | 0.640 |
Why?
| | Multiple Sclerosis | 1 | 2024 | 438 | 0.590 |
Why?
| | Arthroplasty, Replacement, Hip | 4 | 2013 | 137 | 0.580 |
Why?
| | Immunophenotyping | 2 | 2019 | 310 | 0.570 |
Why?
| | Flow Cytometry | 2 | 2019 | 1158 | 0.570 |
Why?
| | Immune System | 1 | 2018 | 174 | 0.530 |
Why?
| | Total Disc Replacement | 2 | 2013 | 14 | 0.510 |
Why?
| | Single-Cell Analysis | 1 | 2018 | 274 | 0.490 |
Why?
| | Materials Testing | 2 | 2013 | 349 | 0.430 |
Why?
| | Polyethylene | 1 | 2013 | 13 | 0.410 |
Why?
| | Cross-Linking Reagents | 2 | 2011 | 206 | 0.410 |
Why?
| | Intervertebral Disc | 1 | 2013 | 39 | 0.400 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 234 | 0.360 |
Why?
| | Prostheses and Implants | 1 | 2010 | 132 | 0.320 |
Why?
| | B-Lymphocytes | 3 | 2023 | 816 | 0.310 |
Why?
| | T-Lymphocytes | 3 | 2023 | 1935 | 0.310 |
Why?
| | Proteome | 2 | 2022 | 440 | 0.270 |
Why?
| | Transcriptome | 2 | 2022 | 875 | 0.240 |
Why?
| | Interferons | 2 | 2022 | 189 | 0.210 |
Why?
| | Lymphopenia | 1 | 2023 | 60 | 0.210 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 2023 | 64 | 0.210 |
Why?
| | Common Variable Immunodeficiency | 1 | 2023 | 26 | 0.200 |
Why?
| | Reoperation | 4 | 2013 | 542 | 0.200 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2023 | 135 | 0.200 |
Why?
| | Blood | 1 | 2022 | 105 | 0.180 |
Why?
| | Ikaros Transcription Factor | 1 | 2021 | 23 | 0.180 |
Why?
| | Pneumonia, Pneumocystis | 1 | 2021 | 36 | 0.180 |
Why?
| | T-Lymphocyte Subsets | 1 | 2023 | 412 | 0.180 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2021 | 66 | 0.180 |
Why?
| | Seroconversion | 1 | 2021 | 46 | 0.170 |
Why?
| | RNA, Viral | 1 | 2024 | 620 | 0.170 |
Why?
| | Humans | 22 | 2024 | 129527 | 0.170 |
Why?
| | Databases, Genetic | 1 | 2021 | 227 | 0.170 |
Why?
| | Interferon-gamma | 1 | 2023 | 773 | 0.160 |
Why?
| | Interleukin-2 Receptor beta Subunit | 1 | 2019 | 18 | 0.160 |
Why?
| | Haploinsufficiency | 1 | 2019 | 48 | 0.160 |
Why?
| | CTLA-4 Antigen | 1 | 2019 | 87 | 0.150 |
Why?
| | Microscopy, Electron, Scanning | 3 | 2013 | 196 | 0.150 |
Why?
| | Metabolome | 1 | 2021 | 338 | 0.140 |
Why?
| | Equipment Failure Analysis | 3 | 2013 | 130 | 0.130 |
Why?
| | Chlamydia trachomatis | 1 | 2016 | 46 | 0.130 |
Why?
| | Lung Diseases, Interstitial | 1 | 2023 | 611 | 0.130 |
Why?
| | RNA, Messenger | 1 | 2024 | 2697 | 0.130 |
Why?
| | Interferon Type I | 1 | 2016 | 139 | 0.120 |
Why?
| | Killer Cells, Natural | 1 | 2019 | 426 | 0.120 |
Why?
| | Cell Death | 1 | 2016 | 352 | 0.120 |
Why?
| | Mutation | 3 | 2021 | 3702 | 0.110 |
Why?
| | Arthroplasty, Replacement, Elbow | 1 | 2013 | 3 | 0.100 |
Why?
| | Joint Capsule | 1 | 2013 | 10 | 0.100 |
Why?
| | Osteolysis | 1 | 2013 | 18 | 0.100 |
Why?
| | Artifacts | 1 | 2013 | 127 | 0.100 |
Why?
| | Datasets as Topic | 2 | 2022 | 109 | 0.090 |
Why?
| | Joint Instability | 1 | 2013 | 166 | 0.090 |
Why?
| | Child | 3 | 2023 | 20932 | 0.090 |
Why?
| | Bacterial Proteins | 1 | 2016 | 837 | 0.090 |
Why?
| | Giant Cells | 1 | 2010 | 23 | 0.090 |
Why?
| | Membrane Proteins | 1 | 2016 | 1118 | 0.080 |
Why?
| | Cytokines | 1 | 2018 | 2018 | 0.080 |
Why?
| | Adaptive Immunity | 1 | 2011 | 161 | 0.080 |
Why?
| | Sodium Hydroxide | 1 | 2009 | 8 | 0.080 |
Why?
| | Nitric Acid | 1 | 2009 | 5 | 0.080 |
Why?
| | Potassium Compounds | 1 | 2009 | 8 | 0.080 |
Why?
| | Caustics | 1 | 2009 | 7 | 0.080 |
Why?
| | Hydroxides | 1 | 2009 | 26 | 0.080 |
Why?
| | Indicators and Reagents | 1 | 2009 | 108 | 0.080 |
Why?
| | Joint Prosthesis | 1 | 2009 | 17 | 0.080 |
Why?
| | Receptors, Antigen, T-Cell | 2 | 2023 | 707 | 0.080 |
Why?
| | Intervertebral Disc Displacement | 1 | 2009 | 39 | 0.080 |
Why?
| | Femur | 1 | 2010 | 243 | 0.070 |
Why?
| | Acetabulum | 1 | 2009 | 106 | 0.070 |
Why?
| | Low Back Pain | 1 | 2009 | 105 | 0.070 |
Why?
| | Signal Transduction | 4 | 2023 | 4916 | 0.070 |
Why?
| | Swine | 1 | 2009 | 760 | 0.070 |
Why?
| | Female | 8 | 2021 | 68650 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2011 | 1684 | 0.070 |
Why?
| | Male | 6 | 2021 | 63586 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2022 | 3383 | 0.050 |
Why?
| | CD28 Antigens | 1 | 2023 | 48 | 0.050 |
Why?
| | Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2023 | 21 | 0.050 |
Why?
| | Middle Aged | 4 | 2021 | 31087 | 0.050 |
Why?
| | Receptors, Antigen, B-Cell | 1 | 2023 | 126 | 0.050 |
Why?
| | Animals | 4 | 2023 | 35334 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 30 | 0.040 |
Why?
| | Access to Information | 1 | 2021 | 47 | 0.040 |
Why?
| | Lymphocytes | 1 | 2023 | 377 | 0.040 |
Why?
| | Particle Size | 2 | 2013 | 354 | 0.040 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 157 | 0.040 |
Why?
| | Data Mining | 1 | 2021 | 110 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2023 | 546 | 0.040 |
Why?
| | Hematopoiesis | 1 | 2021 | 184 | 0.040 |
Why?
| | Mice | 3 | 2023 | 16973 | 0.040 |
Why?
| | Antibodies, Viral | 1 | 2023 | 602 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 2019 | 52 | 0.040 |
Why?
| | Ipilimumab | 1 | 2019 | 31 | 0.040 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5468 | 0.040 |
Why?
| | Interleukin-15 | 1 | 2019 | 83 | 0.040 |
Why?
| | Homozygote | 1 | 2019 | 195 | 0.040 |
Why?
| | Siblings | 1 | 2019 | 216 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 385 | 0.040 |
Why?
| | Complement System Proteins | 1 | 2021 | 318 | 0.040 |
Why?
| | Inpatients | 1 | 2022 | 476 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2019 | 437 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2023 | 1058 | 0.030 |
Why?
| | Homeostasis | 1 | 2021 | 605 | 0.030 |
Why?
| | Cytomegalovirus Infections | 1 | 2019 | 190 | 0.030 |
Why?
| | Interferon Regulatory Factor-3 | 1 | 2016 | 17 | 0.030 |
Why?
| | Aged | 2 | 2013 | 22063 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2023 | 855 | 0.030 |
Why?
| | Vero Cells | 1 | 2016 | 66 | 0.030 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 398 | 0.030 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 372 | 0.030 |
Why?
| | Comorbidity | 1 | 2021 | 1548 | 0.030 |
Why?
| | Metabolomics | 1 | 2021 | 652 | 0.030 |
Why?
| | Autoimmune Diseases | 1 | 2019 | 428 | 0.030 |
Why?
| | HeLa Cells | 1 | 2016 | 611 | 0.030 |
Why?
| | Proteomics | 1 | 2021 | 1053 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2021 | 1684 | 0.030 |
Why?
| | Models, Molecular | 1 | 2019 | 1487 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1717 | 0.030 |
Why?
| | Chromium Alloys | 1 | 2013 | 5 | 0.030 |
Why?
| | Autoimmunity | 1 | 2019 | 863 | 0.030 |
Why?
| | Sampling Studies | 1 | 2013 | 96 | 0.030 |
Why?
| | Bone Cements | 1 | 2013 | 42 | 0.030 |
Why?
| | Inflammation | 1 | 2023 | 2741 | 0.020 |
Why?
| | Titanium | 1 | 2013 | 76 | 0.020 |
Why?
| | Melanoma | 1 | 2019 | 728 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2019 | 2367 | 0.020 |
Why?
| | Adolescent | 1 | 2010 | 20409 | 0.020 |
Why?
| | Hospitalization | 1 | 2021 | 2076 | 0.020 |
Why?
| | Preoperative Care | 1 | 2013 | 337 | 0.020 |
Why?
| | Phenotype | 1 | 2019 | 3058 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2019 | 10232 | 0.020 |
Why?
| | Young Adult | 2 | 2021 | 12438 | 0.020 |
Why?
| | Infant | 1 | 2023 | 9005 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3968 | 0.020 |
Why?
| | Adult | 2 | 2021 | 35505 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1842 | 0.020 |
Why?
| | Device Removal | 1 | 2009 | 136 | 0.020 |
Why?
|
|
Baxter's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|